[1]
Selmer, J., Vestbjerg, B., Præstegaard, M. and Gold, L.S. 2020. Phase 3 Trial Demonstrates that MC2-01 Cream has Improved Treatment Efficacy Compared to Calcipotriene Plus Betamethasone Dipropionate Topical Suspension in Patients with Mild to Moderate Psoriasis Vulgaris. SKIN The Journal of Cutaneous Medicine. 4, 5 (Sep. 2020), s36. DOI:https://doi.org/10.25251/skin.4.supp.36.